4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000130
CFO and Secretary sold 10,758 shares at an average $42.01 ($451,984)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Adam Scott CFO and Secretary | 2025-10-13 | Sale 10b5-1 | −7,366 | $41.90 | $308,651 | 120,257 | D |
| Levy Adam Scott CFO and Secretary | 2025-10-13 | Sale 10b5-1 | −3,392 | $42.26 | $143,333 | 116,865 | D |
| Open-market sales · 10,758 sh · avg $42.01 · $451,984 | |||||||
Loading xslF345X05/wk-form4_1760569476.xml…